Lassa Fever kills 263 in Nigeria in 2026 as fatality rate rises to 23.6%

By Kazeem Ugbodaga

Nigeria has actually taped 263 deaths from Lassa fever in the very first 38 epidemiological weeks of 2026, with the death rate increasing to 23.6 percent, compared to 18.5 percent throughout the matching duration in 2025, according to the Nigeria Centre for Disease Control and Prevention (NCDC).

The firm revealed this in its Lassa Fever Situation Report for Epidemiological Week 38, covering September 14 to 20, 2026, which revealed that the nation had actually taped 1,115 verified cases and 6 possible cases from 8,218 believed cases since the reporting week.

The report showed that the 263 deaths taped amongst verified cases represented a considerable boost from the 168 deaths reported throughout the very same duration in 2025, when 906 verified cases were taped.

According to the NCDC, 24 states and 119 city government locations had actually tape-recorded a minimum of one verified case of the illness in 2026 since epidemiological week 38.

5 states represented 87 percent of all validated cases, highlighting the concentration of the break out in a handful of places.

Ondo State represented the greatest percentage at 35 percent, followed by Bauchi with 23 percent, Taraba with 12 percent, Edo with 11 percent and Benue with 6 percent.

The report revealed that Ondo had actually taped 393 validated cases and 91 deaths, while Bauchi reported 260 validated cases and 36 deaths.

Taraba taped 133 verified cases and 43 deaths, while Edo had 122 validated cases and 27 deaths. Benue taped 61 verified cases and 15 deaths.

Together, the 5 states represented the frustrating bulk of verified infections reported nationally.

Brand-new validated infections decreased throughout the newest reporting week, deaths continued to be tape-recorded.

The NCDC reported 11 brand-new validated cases in epidemiological week 38, below 17 in the preceding week. The brand-new infections were tape-recorded in Ondo, Edo and Taraba states.

4 deaths were tape-recorded amongst validated cases throughout the week, representing a case casualty rate of 36.4 per cent for the reporting duration.

The weekly death rate was greater than the cumulative rate of 23.6 percent tape-recorded for the year, although the 2 figures cover various reporting durations and case overalls.

The company likewise reported 120 presumed cases throughout the week, without any brand-new likely cases tape-recorded.

No extra health care employee was impacted throughout the reporting week, although the cumulative variety of health care employees impacted by Lassa fever in 2026 stood at 54.

The NCDC report determined individuals aged 21 to 30 years as the most afflicted age, with verified cases taped amongst people varying from one to 93 years of ages. The average age of afflicted clients was 30 years.

The report likewise revealed that the male-to-female ratio amongst validated cases was 1:0.9, suggesting a broadly comparable circulation in between the sexes.

The company determined late discussion at health centers as one of the significant obstacles adding to the high death rate.

It likewise highlighted bad health-seeking behaviour related to the high expense of treatment and scientific management, insufficient ecological sanitation in high-burden neighborhoods, minimal public awareness and infections amongst health care employees.

The NCDC advised that state federal governments enhance neighborhood engagement on Lassa fever avoidance throughout the year.

It advised health care employees to preserve a high level of suspicion for the illness, guarantee prompt recommendation and treatment, and adhere strictly to basic infection avoidance and control treatments.

The company likewise required more powerful state capability to avoid, find and react without delay to break outs.


Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND

Subscribe to get the latest posts sent to your email.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Captcha verification failed!
CAPTCHA user score failed. Please contact us!